# Originality, Research Positioning and Business Thesis

**No claim of inventing multi-agent safety, model checking, systematic concurrency testing, or invariant verification.** These are established research and engineering areas.

## Distinctive product proposal
RUKSA CHORD combines an accessible web-based **global safety invariant designer**, AI-generated experimental hypotheses, sandboxed executable multi-agent code, independent violation checking, minimal counterexample replay, approval-gated coordination patch and before/after proof. Users bring a collective problem, not a reverse-engineering target.

## Why distinct from REA
REA investigates existing programs, binaries and application behaviour through MCP/CLI. CHORD deliberately composes **multiple cooperative but independently acting synthetic agents** and evaluates the resulting shared-state safety. It does not inspect binaries, scrape real sites, or reconstruct legacy UI; it tests interactions and coordination policies.

## Why distinct from generic sandbox tools
Isolation is a substrate for experimentation, not the user-visible product. The user sees conflicting agent decisions, a violated global invariant, and a constrained policy fix; runtime safety controls make experiments responsibly executable.

## Why distinct from simple race-condition analyzers
CHORD's intended user is an AI-workflow owner, not a concurrency researcher. The vision spans agent permissions, event-driven tasks, retry/idempotency handling and cross-agent outcomes, with generated experiments and accessible evidence; the current prototype is one minimal seed, not this complete platform.

## Commercial wedge
A staging-time **Collective Safety Gate** for teams deploying automated purchasing, support escalation or internal operations agents. They can test coordination and produce evidence before granting production side-effect permissions. Business value remains hypothetical until real user studies and production staging pilots.

## Research hypothesis
Can an AI planner find high-value interaction schedules with fewer trial runs than naive bounded enumeration while preserving transparent test coverage and no false VERIFIED claims? This is a testable proposed investigation, not a discovery claim.

## Competitive risk
Products and papers exist for multi-agent evaluation, systematic schedule exploration and chaos/testing platforms. Differentiate with actual measurable outcomes, not naming. Proof of concept should compare bounded exhaustive coverage against any model-selected probe subset only after both are implemented.
